Cortexyme
Cortexyme is a biotechnology company with a focus on developing therapeutics for Alzheimer's disease and other neurodegenerative diseases. It was founded in 2012 and is located in San Francisco, California.
4
Funding Rounds
$278.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca*** Ly*** | - | - | |
| St*** Do**** | - | - | - |
| Kr***** Ga**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Un* Ry** | - | - | - |
| Ph**** Lo* | - | - | |
| Di** Th** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cortexyme has raised a total of $202m in funding over 4 rounds.
Key Insights:
- Cortexyme Private equity, February 2020: $125m
- Cortexyme Series B round, May 2018: $76m
- Cortexyme Seed round, October 2014: $1m
- Cortexyme, Inc. funding round, June 2018: $76m
Cortexyme Private equity, February 2020
$125m
Cortexyme Series B round, May 2018
$76m
Cortexyme Seed round, October 2014
$1m
Cortexyme, Inc. funding round, June 2018
$76m
Industries
Cortexyme is active in the following industries:
- Healthcare
- Pharmaceutical industry
- Biomedical engineering
- Neuroscience
- Alzheimer's disease
- Consumer biotechnology
- Engineering
- Technology
- Biology
- Biotechnology
- Synthetic chemistry
- Neurodegenerative Disease